In a significant and up-to-date policy shift, the NCAA (National Collegiate Athletic Association) medical committee has recommended that college athletes should no longer face penalties for using cannabis. This progressive stance reflects the evolving landscape of cannabis regulations across the United States. The committee has firmly asserted that drug testing efforts should be redirected towards detecting performance-enhancing substances, leaving cannabis use without punitive measures. This recommendation comes after the committee conducted a thorough review of existing policies and solicited input from member organizations. It anticipates that the final decision on this matter will be made in the fall, following consultations and legislative processes within each of the NCAA’s governing bodies.

The basis for the medical committee’s recommendation is rooted in insights derived from the 2022 Summit on Cannabinoids in College Athletics. During this summit, experts in the field shared their research findings and policy perspectives related to cannabis. The consensus among these experts was that cannabis does not confer any performance-enhancing advantages, and a harm-reduction approach to its use is most effective when implemented at the school level.

In addition to advocating for the removal of cannabis from the list of banned substances, the committee is proposing a redirection of drug testing efforts towards substances that genuinely enhance athletic performance. They also stress the importance of educating student-athletes about the potential health risks associated with contemporary cannabis use and the various methods of consumption.

This move by the NCAA medical committee is part of a broader trend of sports organizations reconsidering their approaches to cannabis use in light of decriminalization efforts sweeping across the United States. The National Basketball Association (NBA), for instance, recently reached a tentative agreement with the NBA Players Association in April, stipulating that players would no longer be subjected to testing or penalties for cannabis use. This marks a significant departure from the NBA’s previous policy, which included a mandatory treatment program after the first offense, a $25,000 fine for the second violation, and a five-game suspension after the third offense, as reported by Forbes. Notably, former NBA player Al Harrington, in an interview with GQ in 2021, estimated that around 85% of players in the league either use cannabis or some form of it. He emphasized that for many athletes, cannabis serves as a safe and alternative way to cope with the immense stress and pressures they face.

The case of Sha’carri Richardson, a former standout track athlete from LSU, further underscores the contentiousness surrounding cannabis use in sports. Richardson tested positive for THC metabolites, a component found in cannabis, ahead of the 2021 Tokyo Olympics and was subsequently disqualified from competing. She later revealed that she had used cannabis to help cope with the pressures of performing on the world’s biggest stage and the recent loss of her mother.

President Joe Biden, when asked about Richardson’s suspension, acknowledged that while the rules were known to all participants, the broader question of whether those rules should remain in place warrants consideration. The public discourse surrounding Richardson’s case, along with the evolving views on cannabis use, has contributed to an ongoing reevaluation of policies within athletic organizations.

As the NCAA medical committee progresses towards reforming its stance on cannabis, it signifies a progressive and empathetic approach to the well-being of student-athletes. By shifting the focus of drug testing efforts towards performance-enhancing substances, while simultaneously providing education on the risks associated with cannabis use, the committee aims to foster a safer and more informed environment for college athletes. As discussions continue and decisions are finalized, the NCAA has the opportunity to set a precedent that prioritizes the evolving needs and perspectives of its student-athletes in an ever-changing landscape of drug policies and societal attitudes.


Source: Business Insider


Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Revolutionary Shift: US Health Department Proposes Reclassifying Marijuana from Schedule I to Schedule III

In a groundbreaking move that has the potential to reshape the landscape of cannabis regulations, the U.S. Department of Health and Human Services (HHS) has taken a bold step by formally recommending the reclassification of marijuana from Schedule I to Schedule III under federal law. This historic decision signifies a seismic shift in perspective, indicating that the nation’s premier health agency no longer views cannabis as a substance with high abuse potential and zero medical value.

Challenges in California’s Legal Marijuana Industry: High Costs and Compliance Hurdles

California’s legal marijuana industry is facing significant challenges, with high taxes and regulatory obstacles driving entrepreneurs towards the illicit market, according to the state’s Attorney General Rob Bonta. In a recent event held in Fresno, Bonta highlighted the excessive barriers to entry and operational costs as major roadblocks for businesses operating within the legal framework. He suggested that temporary tax reductions could be beneficial to ease the burden on legitimate operators.

Proposed Legislation Aims to Address Cannabis Taxation Issues in California

Under the Adult Use of Marijuana Act, the cannabis excise tax in California is currently set at 15% of gross receipts from licensed retail cannabis sales. In addition to this state-level tax, many local governments impose their own additional taxes on cannabis, with some jurisdictions, including Los Angeles, charging as high as 10%.